AAAAAA

   
Results: 1-11 |
Results: 11
Parathyroid hormone/parathyroid hormone-related peptide type 1 receptor inhuman bone
Authors: Langub, MC Monier-Faugere, MC Qi, QL Geng, Z Koszewski, NJ Malluche, HH
Citation: Mc. Langub et al., Parathyroid hormone/parathyroid hormone-related peptide type 1 receptor inhuman bone, J BONE MIN, 16(3), 2001, pp. 448-456
Improved assessment of bone turnover by the PTH-(1-84) large C-PTH fragments ratio in ESRD patients
Authors: Monier-Faugere, MC Geng, ZP Mawad, H Friedler, RM Gao, P Cantor, TL Malluche, HH
Citation: Mc. Monier-faugere et al., Improved assessment of bone turnover by the PTH-(1-84) large C-PTH fragments ratio in ESRD patients, KIDNEY INT, 60(4), 2001, pp. 1460-1468
High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation
Authors: Monier-Faugere, MC Mawad, H Qi, QL Friedler, RM Malluche, HH
Citation: Mc. Monier-faugere et al., High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation, J AM S NEPH, 11(6), 2000, pp. 1093-1099
Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow
Authors: Maluche, HH Monier-Faugere, MC
Citation: Hh. Maluche et Mc. Monier-faugere, Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow, CLIN NEPHR, 54(4), 2000, pp. 309-317
Short-term administration of the bisphosphonate ibandronate increases bonevolume and prevents hyperparathyroid bone changes in mild experimental renal failure
Authors: Geng, Z Monier-Faugere, MC Bauss, F Malluche, HH
Citation: Z. Geng et al., Short-term administration of the bisphosphonate ibandronate increases bonevolume and prevents hyperparathyroid bone changes in mild experimental renal failure, CLIN NEPHR, 54(1), 2000, pp. 45-53
Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation
Authors: Zhao, G Monier-Faugere, MC Langub, MC Geng, Z Nakayama, T Pike, JW Chernausek, SD Rosen, CJ Donahue, LR Malluche, HH Fagin, JA Clemens, TL
Citation: G. Zhao et al., Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation, ENDOCRINOL, 141(7), 2000, pp. 2674-2682
Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: Effects on bone morphometry and mineral properties
Authors: Monier-Faugere, MC Geng, ZP Paschalis, EP Qi, QL Arnala, I Bauss, F Boskey, AL Malluche, HH
Citation: Mc. Monier-faugere et al., Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: Effects on bone morphometry and mineral properties, J BONE MIN, 14(10), 1999, pp. 1768-1778
Understanding and managing hyperphosphatemia in patients with chronic renal disease
Authors: Malluche, HH Monier-Faugere, MC
Citation: Hh. Malluche et Mc. Monier-faugere, Understanding and managing hyperphosphatemia in patients with chronic renal disease, CLIN NEPHR, 52(5), 1999, pp. 267-277
The role of bone biopsy in clinical practice and research
Authors: Malluche, HH Langub, MC Monier-Faugere, MC
Citation: Hh. Malluche et al., The role of bone biopsy in clinical practice and research, KIDNEY INT, 56, 1999, pp. S20-S25
22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducinglow bone turnover in dogs with renal failure
Authors: Monier-Faugere, MC Geng, ZP Friedler, RM Qi, QL Kubodera, N Slatopolsky, E Malluche, HH
Citation: Mc. Monier-faugere et al., 22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducinglow bone turnover in dogs with renal failure, KIDNEY INT, 55(3), 1999, pp. 821-832
The phytoestrogen genistein reduces bone loss in short-term ovariectomizedrats
Authors: Fanti, P Monier-Faugere, MC Geng, Z Schmidt, J Morris, PE Cohen, D Malluche, HH
Citation: P. Fanti et al., The phytoestrogen genistein reduces bone loss in short-term ovariectomizedrats, OSTEOPOR IN, 8(3), 1998, pp. 274-281
Risultati: 1-11 |